The 68-week STEP 1 trial showed 14.9% mean body weight reduction at 2.4mg, compared to retatrutide hitting 17.5% at just 24 weeks with the 12mg dose
Glapp is a GLP-1 tracker app that helps you track injections (shots, jabs), weight loss, side effects, and injection reminders so you can better understand how semaglutide or tirzepatide affects your body over time
While theres no one-size-fits-all approach, paying attention to how you feel and seeking guidance early can make the process easier to manage
Yurpeak (tirzepatide) acts on both GIP and GLP-1 receptors, whereas semaglutide (Ozempic) acts only on GLP-1 receptors
Work closely with your endocrinologist to establish a monitoring plan that covers the transition from tirzepatide treatment through conception and pregnancy
If you experience severe symptoms such as confusion, difficulty breathing, or persistent vomiting, call 999